New York University

FILTER
Selected:

MIT-led team receives funding to pursue new treatments for metabolic disease

February 8, 2024

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.